November 02, 2020
Jounce Therapeutics
Jounce Therapeutics Announces Update on Vopratelimab Program
November 02, 2020
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results
November 02, 2020
Sesen Bio
Sesen Bio to Host Conference Call to Review Third Quarter Financial Results and Provide an Update on Positive Progress Towards Demonstration of Analytical Comparability
November 02, 2020
Decibel Therapeutics
Decibel Therapeutics Announces Exclusive Licensing Agreements for Hearing Loss Gene Therapy Technology
October 30, 2020
Rhythm Pharmaceuticals
Rhythm Pharmaceuticals Announces Publication of Results from Phase 3 Clinical Trials of Setmelanotide in The Lancet Diabetes & Endocrinology